What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibiotics
- Tuberculosis
His scientific interests lie mostly in Tuberculosis, Pharmacology, Isoniazid, Pyrazinamide and Mycobacterium tuberculosis.
His Tuberculosis research includes elements of Internal medicine, Pharmacotherapy, Immunology and Drug resistance.
His research integrates issues of Moxifloxacin and Bedaquiline in his study of Pharmacology.
As a member of one scientific family, Eric L. Nuermberger mostly works in the field of Isoniazid, focusing on Antibacterial agent and, on occasion, Rifampicin and Chemotherapy.
The various areas that Eric L. Nuermberger examines in his Pyrazinamide study include Regimen, Ethambutol and SQ109.
His research in Mycobacterium tuberculosis intersects with topics in In vivo, Granuloma, Mutant and Microbiology.
His most cited work include:
- Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. (682 citations)
- Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin Genes (635 citations)
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis (292 citations)
What are the main themes of his work throughout his whole career to date?
Eric L. Nuermberger mainly investigates Tuberculosis, Pharmacology, Mycobacterium tuberculosis, Pyrazinamide and Regimen.
His Tuberculosis research integrates issues from Internal medicine, Immunology and Drug.
His studies in Pharmacology integrate themes in fields like Moxifloxacin and Rifapentine.
His Mycobacterium tuberculosis study combines topics in areas such as Mutant, Drug resistance, Microbiology, Caseous necrosis and In vivo.
His Pyrazinamide research is within the category of Isoniazid.
In his research, Combination chemotherapy is intimately related to Pharmacotherapy, which falls under the overarching field of Regimen.
He most often published in these fields:
- Tuberculosis (80.31%)
- Pharmacology (56.37%)
- Mycobacterium tuberculosis (54.05%)
What were the highlights of his more recent work (between 2018-2021)?
- Tuberculosis (80.31%)
- Pharmacology (56.37%)
- Bedaquiline (22.78%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Tuberculosis, Pharmacology, Bedaquiline, Regimen and Pretomanid.
Pyrazinamide, Mycobacterium tuberculosis, Rifapentine and Isoniazid are among the areas of Tuberculosis where the researcher is concentrating his efforts.
In his study, which falls under the umbrella issue of Pyrazinamide, Nude mouse and Potency is strongly linked to Moxifloxacin.
His studies deal with areas such as Kinase, Immune system and Microbiology as well as Mycobacterium tuberculosis.
The Pharmacology study combines topics in areas such as Clarithromycin, Amikacin and In vivo.
Eric L. Nuermberger focuses mostly in the field of Regimen, narrowing it down to topics relating to Drug and, in certain cases, Vaccine efficacy, Immunology and Acquired immune system.
Between 2018 and 2021, his most popular works were:
- In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus. (33 citations)
- The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis. (32 citations)
- In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates. (28 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibiotics
- Tuberculosis
Eric L. Nuermberger mainly focuses on Tuberculosis, Regimen, Drug resistance, Microbiology and Pharmacology.
His Tuberculosis research is multidisciplinary, incorporating perspectives in Internal medicine and Transporter.
His work deals with themes such as Rifapentine and Isoniazid, which intersect with Internal medicine.
His work focuses on many connections between Regimen and other disciplines, such as Bedaquiline, that overlap with his field of interest in Dosing.
Eric L. Nuermberger interconnects Moxifloxacin, Pyrazinamide, Mycobacterium tuberculosis and Nude mouse in the investigation of issues within Pharmacology.
His Mycobacterium tuberculosis research incorporates themes from Clarithromycin, Rifamycin and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
